Literature DB >> 17721937

Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.

Christopher A Squier1, Mary J Mantz, Patrick M Schlievert, Catherine C Davis.   

Abstract

The vaginal mucosa is commonly exposed to a variety of topical agents, including chemical contraceptives, drugs for the treatment of specific pathological conditions, and pathogenic microorganisms. In vitro models can provide important information regarding the penetration and efficacy of topical compounds as well as the pathogenesis of various diseases such a menstrual toxic shock syndrome. Realistic and reproducible test systems are important if new agents are to fulfill their therapeutic potential in human populations. The selection of appropriate animal species and tissue and the use of valid in vitro systems can avoid many of the shortcomings of current animal and cell culture test systems. This review provides information about the factors that should be considered when selecting the best model to study the permeability of the human vagina. The characteristics of an ex vivo porcine model are explored and the validity of this model is demonstrated in terms of its histology, ultrastructure and composition and organization of the permeability barrier; data indicate excellent correlation of permeability and tissue response between human and porcine vaginal tissue. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17721937     DOI: 10.1002/jps.21077

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  31 in total

1.  Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.

Authors:  Jianing Meng; Tao Zhang; Vivek Agrahari; Miezan J Ezoulin; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2014-01-10       Impact factor: 5.307

2.  Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.

Authors:  Bénédicte Pradines; Christian Bories; Christine Vauthier; Gilles Ponchel; Philippe M Loiseau; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

3.  Ultrasonic thermal damage during robotic hysterectomy.

Authors:  Jason Massengill; Eric Lombardini; Jonathan Oliva; Jerome Buller; Daniel Gruber
Journal:  J Robot Surg       Date:  2014-04-27

4.  Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.

Authors:  Jianing Meng; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Sci       Date:  2011-06-17       Impact factor: 4.384

5.  Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.

Authors:  Ying-Chi Lin; Michele J Anderson; Petra L Kohler; Kristi L Strandberg; Michael E Olson; Alexander R Horswill; Patrick M Schlievert; Marnie L Peterson
Journal:  Biochemistry       Date:  2011-07-21       Impact factor: 3.162

6.  Full depth measurement of tenofovir transport in rectal mucosa using confocal Raman spectroscopy and optical coherence tomography.

Authors:  Aubrey L Presnell; Oranat Chuchuen; Morgan G Simons; Jason R Maher; David F Katz
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  A mucosal model to study microbial biofilm development and anti-biofilm therapeutics.

Authors:  Michele J Anderson; Patrick J Parks; Marnie L Peterson
Journal:  J Microbiol Methods       Date:  2012-12-14       Impact factor: 2.363

9.  Cytolysins augment superantigen penetration of stratified mucosa.

Authors:  Amanda J Brosnahan; Mary J Mantz; Christopher A Squier; Marnie L Peterson; Patrick M Schlievert
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  Novel toxic shock syndrome toxin-1 amino acids required for biological activity.

Authors:  Amanda J Brosnahan; Matthew M Schaefers; William H Amundson; Mary J Mantz; Christopher A Squier; Marnie L Peterson; Patrick M Schlievert
Journal:  Biochemistry       Date:  2008-12-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.